{"transactions":[{"id":957216,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-30T16:01:08.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":65000,"price":38.7,"value":2515500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.52 to $38.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":109398,"source":{"system":"sec-edgar","filing":"0001193125-25-337052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525337052/ownership.xml","form_type":"4"}},{"id":962048,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":55000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":962047,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":125602,"price":39.45,"value":4954998.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":174398,"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":962046,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":962045,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":1294515,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T16:55:46.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":230000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0000950170-25-009256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000095017025009256/ownership.xml","form_type":"4"}},{"id":1670971,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T16:27:09.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":255000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":255000,"derivative":{"exercise_price":4.63,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":255000},"source":{"system":"sec-edgar","filing":"0000950170-24-007422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000095017024007422/ownership.xml","form_type":"4"}},{"id":2013680,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T15:51:33.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":140000,"derivative":{"exercise_price":13.63,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000899243-23-005140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000089924323005140/doc4.xml","form_type":"4"}},{"id":2424087,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T17:42:26.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":202250,"price":4.9432,"value":999762.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":202250,"derivative":{"exercise_price":7.6,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":202250},"source":{"system":"sec-edgar","filing":"0000899243-22-003469","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000089924322003469/doc4.xml","form_type":"4"}},{"id":2727479,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-05T16:37:20.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period."}],"balance_after":260000,"derivative":{"exercise_price":8.93,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0000899243-21-018362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000089924321018362/doc4.xml","form_type":"4"}},{"id":2936636,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Stock Option (Right to buy)","published_at":"2020-12-21T18:42:15.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan.  One-third of the Stock Option vests on December 17, 2021, with the remaining vesting in eight equal quarterly installments thereafter (provided Mr. Kearns maintains a service relationship with the Company through each such vesting date)."}],"balance_after":150000,"derivative":{"exercise_price":3.7,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001745285-20-000045","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000174528520000045/primary_doc.xml","form_type":"4"}},{"id":3330611,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to buy)","published_at":"2019-12-27T20:34:29.000Z","date":"2019-12-24","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Option vests over a three-year period, with 1/3 of Option vesting on December 24, 2020, and the balance vesting in equal quarterly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":4.12,"expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-19-030103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924319030103/doc4.xml","form_type":"4"}},{"id":3456322,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-25T22:46:48.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option awarded in accordance with Agenus Inc. 2019 Equity Incentive Plan and is eligible to vest, if at all, in a single installment on June 30, 2022 based upon the Company stock price performance.  Amount shown reflects the target award.  The ultimate award size can range between 0% and 150% of target based on the actual average stock price achieved at the end of the performance period."}],"balance_after":18333,"derivative":{"exercise_price":2.39,"expiration_date":"2029-07-23","underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001745285-19-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000174528519000007/primary_doc.xml","form_type":"4"}},{"id":3481736,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"V.P. and General Counsel"}}],"security":"Stock Option(right to buy)","published_at":"2019-06-21T21:27:00.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19,2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. Option vests over a three year period, with 1/3 of Option vesting on January 1, 2020, and the balance vesting in equal quarterly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":2.38,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-19-017832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924319017832/doc4.xml","form_type":"4"}}]}